Business Description
Mentor Capital Inc
NAICS : 523999
SIC : 6799
Description
Mentor Capital Inc acquires and provides liquidity for medical and social use cannabis companies. The company is operating an acquisition and investment business. It operates through two segments namely Cannabis and Medical Marijuana Segment and Facilities Operations related. The cannabis and medical marijuana segment include the operation of subsidiaries in the Cannabis and medical marijuana sector. Mentor's focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson's disease, reducing ocular pressures from glaucoma, and blunting chronic pain.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.24 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 1.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.61 | |||||
| Beneish M-Score | -4.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.7 | |||||
| 3-Year EPS without NRI Growth Rate | 12.6 | |||||
| 3-Year FCF Growth Rate | -2.3 | |||||
| 3-Year Book Growth Rate | -30.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.19 | |||||
| 9-Day RSI | 55.34 | |||||
| 14-Day RSI | 53.28 | |||||
| 6-1 Month Momentum % | 34.44 | |||||
| 12-1 Month Momentum % | -2.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.63 | |||||
| Quick Ratio | 1.63 | |||||
| Cash Ratio | 0.98 | |||||
| Days Sales Outstanding | 33.41 | |||||
| Days Payable | 2.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.67 | |||||
| Operating Margin % | -14.37 | |||||
| Net Margin % | 0.94 | |||||
| ROE % | 3.17 | |||||
| ROA % | 1.34 | |||||
| ROIC % | -24.54 | |||||
| ROC (Joel Greenblatt) % | 54.55 | |||||
| ROCE % | 13.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.17 | |||||
| PE Ratio without NRI | 17.17 | |||||
| Price-to-Owner-Earnings | 1.2 | |||||
| PS Ratio | 0.16 | |||||
| PB Ratio | 0.54 | |||||
| Price-to-Tangible-Book | 1.72 | |||||
| Price-to-Free-Cash-Flow | 0.94 | |||||
| Price-to-Operating-Cash-Flow | 0.92 | |||||
| EV-to-EBIT | 1.59 | |||||
| EV-to-EBITDA | 1.1 | |||||
| EV-to-Revenue | 0.12 | |||||
| EV-to-FCF | 0.71 | |||||
| Price-to-Graham-Number | 1.03 | |||||
| Earnings Yield (Greenblatt) % | 62.89 |
